Dippon VN, Rizvi Z, Choudhry AE, et al. Identification of an allosteric site on the E3 ligase adapter cereblon. Nature. 2026. doi:10.1038/s41586-025-09994-w
Chemical Biology and Therapeutics Science Program
Halim S, Sebastian RM, Liivak KE, et al. Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network. Molecular cell. 2026. doi:10.1016/j.molcel.2025.12.013
Dib C, Queenan JA, Willner H, et al. Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model. Molecular therapy : the journal of the American Society of Gene Therapy. 2026. doi:10.1016/j.ymthe.2026.04.010
Raval S, Shi Y, Morriss JW, et al. Nano-scaled, fully automated hydrogen/deuterium exchange for analysis of macromolecular assemblies reaching the MDa scale. Molecular & cellular proteomics : MCP. 2026:101519. doi:10.1016/j.mcpro.2026.101519
Merz ML, Shoba VM, Pergu R, et al. Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis. ACS central science. 2026;12(4):473-483. doi:10.1021/acscentsci.5c02202
PMCID
PMC13107213
Singh S, Tran K, Karaj E, et al. Lysine Targeting Group-Transfer Chimeras for Proximity Induction. Angewandte Chemie (International ed. in English). 2026:e12131. doi:10.1002/anie.202512131
Nelson AT, Hill SF, Simon M, et al. In vivo adenine base editing ameliorates Dravet syndrome phenotypes in a mouse model. Science translational medicine. 2026;18(849):eadx5999. doi:10.1126/scitranslmed.adx5999
Gao XD, Presa M, Duby JE, et al. In vivo base editing rescues liver pathophysiology and peroxisome dysfunction in a mouse model of Zellweger spectrum disorder. Nature biomedical engineering. 2026. doi:10.1038/s41551-026-01651-5
Kabra M, Moosajee M, Navarrete A, et al. Synonymous editing alters ion channel function, favoring prime editing for retinal disease correction. International journal of biological sciences. 2026;22(9):4670-4690. doi:10.7150/ijbs.132743
PMCID
PMC13182245
Zhang J, Hołubowicz R, Smidak R, et al. A combinatorial synthetic strategy for developing genome-editing protein-delivery agents targeting mouse retina. Nature communications. 2026. doi:10.1038/s41467-026-69077-w